Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
160 Health InternationalFRA:O66 -5.84%8 PS Ratio is 4.29 as of Aug. 19, 2026, which is 79% below its 10-year median of 20.41. GuruFocus rates FRA:O66 with a GF Score™ of 8/100. The stock has 5 warning signs investors should review. Among 118 Medical Distribution companies, 160 Health International ranks worse than 93.22% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, 160 Health International's share price is €1.064.
160 Health International's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €0.25. Hence, 160 Health International's PS Ratio for today is 4.29.
Good Sign:
160 Health International Ltd stock PS Ratio (=4.06) is close to 1-year low of 3.95.
The historical rank and industry rank for 160 Health International's PS Ratio or its related term are showing as below:
FRA:O66'
s PS Ratio Range Over the Past 10 Years
Min: 3.95 Med: 20.41 Max: 57.53
Current: 4.27
During the past 4 years, 160 Health International's highest PS Ratio was 57.53. The lowest was 3.95. And the median was 20.41.
FRA:O66's PS Ratio is ranked worse than 93.22% of 118
companies
in the Medical Distribution industry
Industry Median: 0.425
vs FRA:O66: 4.27
During the past 4 years, 160 Health International's highest 3-Year average Revenue per Share Growth Rate was 10.80% per year. The lowest was 10.80% per year. And the median was 10.80% per year.
160 Health International (FRA:O66) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, 160 Health International's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
160 Health International PS Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, 160 Health International's PS Ratio distribution charts can be found below:
* The bar in red indicates where 160 Health International's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
160 Health International's Share Price of today is €1.064.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. 160 Health International's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €0.25.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
160 Health International (FRA:O66) has a PS Ratio of 4.29 as of Aug. 19, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on 160 Health International and its competitors. This is 79% below median its historical median of 20.41. Over the past decade, 160 Health International's PS Ratio has ranged from 3.95 to 57.53. According to the industry distribution chart, 160 Health International ranks #110 out of 118 companies in the Medical Distribution industry, placing it in the top 93.2%.
Is 160 Health International's PS Ratio too high?
160 Health International's current PS Ratio of 4.29 is 79% below median its 10-year median of 20.41. Over the past 10 years, this metric has ranged from a low of 3.95 to a high of 57.53. The Medical Distribution industry median PS Ratio is 0.43. 160 Health International's value of 4.29 is 909.4% above this industry median. Based on the distribution chart, 160 Health International ranks #110 out of 118 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, 160 Health International has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does 160 Health International's PS Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, 160 Health International ranks #110 out of 118 companies for PS Ratio. This places 160 Health International in the lower half of its industry. The industry median PS Ratio is 0.43. 160 Health International's value of 4.29 is 909.4% above this benchmark. Historically, 160 Health International's own PS Ratio has ranged from 3.95 to 57.53 over the past decade. While the company's 10-year median is 20.41 vs. the industry median of 0.43, 160 Health International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Distribution company?
The median PS Ratio among Medical Distribution companies is 0.43, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 160 Health International's current PS Ratio of 4.29 is 909.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on 160 Health International and its competitors. For the Medical Distribution industry, the median PS Ratio is 0.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 160 Health International's current PS Ratio is 4.29, which is 79% below median its own 10-year median of 20.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 160 Health International stock overvalued right now?
160 Health International (FRA:O66) has a current PS Ratio of 4.29. The current PS Ratio is 4.29, which is 79% below median its 10-year median of 20.41 and 909.4% above the Medical Distribution industry median of 0.43. 160 Health International's overall GF Score™ is 8/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For 160 Health International (FRA:O66), the current PS Ratio is 4.29 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
160 Health International Ltd is an experienced pharmaceutical and healthcare product wholesaler and a digital healthcare integrated service provider in China. The company offers a wide assortment of high-quality pharmaceutical and healthcare products under both wholesale and retail models, to address a spectrum of customer needs. In addition, through its online healthcare and wellness service platform, Healthcare 160 Platform. It also provide digital healthcare and wellness solutions, empowering each Platform Participants, including business customers, medical and healthcare institutions, medical professionals, individual users, and third-party merchants, throughout the healthcare value chain and driving the digital transformation of China's healthcare and wellness industry.
8GF Score
Get the complete analysis for FRA:O66
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:O66 has been successfully added to your 
